Kaposi's sarcoma-associated herpesvirus: Epidemiology, biological characteristics and pathogenesis

Keyphrases

• Epidemiology 100%
• Biological Characteristics 100%
• Kaposi's Sarcoma-associated Herpesvirus 100%
• Idiopathic multicentric Castleman Disease (iMCD) 14%
• Non-heterosexual 14%
• South America 7%
• North America 7%
• Next-generation Sequencing 7%
• Causative Agents 7%
• Clinical Practice 7%
• In Vitro Study 7%
• Adulthood 7%
• Patients at Risk 7%
• Northern Europe 7%
• Saliva 7%
• Mediterranean Area 7%
• Distinctive Features 7%
• Infectious Virus 7%
• Pathological Conditions 7%
• Asia 7%
• Population-based 7%
• Small Parts 7%
• Kaposi Sarcoma 7%
• Host Immune Response 7%
• HHV-8 7%
• Seroprevalence 7%
• Primary Effusion Lymphoma 7%
• MicroRNA 7%
• Predisposing Factors 7%
• Inflammatory Cytokines 7%
• Gene Products 7%
• Pathogenic Mechanism 7%
• Prognostic Biomarker 7%
• Diagnostic Test 7%
• Host Gene Expression 7%
• Sub-Saharan Africa 7%
• Therapeutic Strategies 7%
• Melanesian 7%
• Infected Cells 7%
• Droplet Digital PCR (ddPCR) 7%
• Latent Genes 7%
• Recombinant Virus 7%
• New Diagnostics 7%
• Cell Transformation 7%
• Sexual Contact 7%
• Predictive Biomarker 7%
• Lytic Phase 7%
• Cytokine Release Syndrome 7%
• Oncogenic Properties 7%
• Cell Immortalization 7%
• Viral microRNA 7%
• Herpesvirus Infection 7%
• Middle Eastern Countries 7%
• Plasmablastic 7%
• Technological Tools 7%
• Cellular microRNAs 7%
• Inflammatory Microenvironment 7%
• Model Virus 7%
• Low Seroprevalence 7%
• Genomic Instability 7%
• Related Disorders 7%

Medicine and Dentistry

• Cohort Effect 100%
• Human Herpesvirus 8 100%
• microRNA 20%
• Angiofollicular Lymph Node Hyperplasia 13%
• Seroprevalence 13%
• Disease 6%
• Diagnosis 6%
• In Vitro 6%
• Virus Infectivity 6%
• Gene Expression 6%
• Immune System 6%
• Biological Marker 6%
• Kaposi Sarcoma 6%
• Polymerase Chain Reaction 6%
• Disease Predisposition 6%
• Inflammatory Cytokine 6%
• Herpes Virus Infection 6%
• Next Generation Sequencing 6%
• Cell Transformation 6%
• Virus Recombinant 6%
• Cell Immortalization 6%
• Primary Effusion Lymphoma 6%
• Gene Product 6%

Immunology and Microbiology

• Human Herpesvirus 8 100%
• Castleman's Disease 13%
• Seroprevalence 13%
• Next Generation Sequencing 6%
• Recombinant Virus 6%
• Inflammatory Cytokine 6%
• Polymerase Chain Reaction 6%
• Immune System 6%
• Gene Expression 6%
• Virus Infectivity 6%
• Animal Experiment 6%
• Cell Immortalization 6%
• Cell Transformation 6%
• Gene Product 6%